Healing rate of macular edema secondary to branch retinal vein occlusion in two years after initiation of intravitreal ranibizumab later combined with other treatment as needed and characteristics of refractory cases

PURPOSE: To investigate the 2-year healing rate of macular edema (ME) secondary to branch retinal vein occlusion (BRVO) treated initially with intravitreal ranibizumab (IVR) and later combined with other treatment as needed, and the characteristics of refractory cases. METHODS: 130 patients (130 eye...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Setsuko, Wakabayashi, Yoshihiro, Watanabe, Yoko, Umazume, Kazuhiko, Yamamoto, Kaori, Goto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810186/
https://www.ncbi.nlm.nih.gov/pubmed/36595494
http://dx.doi.org/10.1371/journal.pone.0278968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810186/
https://www.ncbi.nlm.nih.gov/pubmed/36595494
http://dx.doi.org/10.1371/journal.pone.0278968

Ejemplares similares